Barclays' Biopharmaceuticals Blueprint For 2016 By: Benzinga via Benzinga December 01, 2015 at 11:54 AM EST Geoff Meacham of Barclays initiated coverage of six names within the "newly combined" U.S. Biopharmaceuticals ... Read More >> Related Stocks: AbbVie Bristol-Myers Squibb Eli Lilly Johnson & Johnson Merck & Co